Skip to content
10-Q

Quarterly Report

P3 Health Partners Inc. PIII PIIIW

0001832511-26-000022

← back to feed
Filed
May 14, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted Q1 2026 · Mar 31, 2026 8.42M sh
Shares Diluted Q1 2026 · Mar 31, 2025 3.26M sh
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$27.47M
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$33.47M
Long Term Debt Q1 2026 · Mar 31, 2026 $259.57M
Long Term Debt Q1 2026 · Dec 31, 2025 $228.37M
Short Term Debt Q1 2026 · Mar 31, 2026 $835K
Short Term Debt Q1 2026 · Dec 31, 2025 $0
Cash And Equivalents Q1 2026 · Mar 31, 2026 $25.5M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $25.01M
Cash And Equivalents Q1 2026 · Mar 31, 2025 $40.08M
Current Liabilities Q1 2026 · Mar 31, 2026 $525.49M
Current Liabilities Q1 2026 · Dec 31, 2025 $545.26M
Total Liabilities Q1 2026 · Mar 31, 2026 $807.32M
Total Liabilities Q1 2026 · Dec 31, 2025 $796.88M
Current Assets Q1 2026 · Mar 31, 2026 $172.21M
Current Assets Q1 2026 · Dec 31, 2025 $133.08M
Total Assets Q1 2026 · Mar 31, 2026 $674.16M
Total Assets Q1 2026 · Dec 31, 2025 $656.64M
Eps Diluted Q1 2026 · Mar 31, 2026 $0.32
Eps Diluted Q1 2026 · Mar 31, 2025 −$6.28
Eps Basic Q1 2026 · Mar 31, 2026 $0.37
Eps Basic Q1 2026 · Mar 31, 2025 −$6.28
Sga Expense Q1 2026 · Mar 31, 2026 $25.54M
Sga Expense Q1 2026 · Mar 31, 2025 $25M
Net Income Q1 2026 · Mar 31, 2026 $1.22M
Net Income Q1 2026 · Mar 31, 2025 −$20.48M
Operating Income Q1 2026 · Mar 31, 2026 $8.24M
Operating Income Q1 2026 · Mar 31, 2025 −$38.09M
Revenue Q1 2026 · Mar 31, 2026 $386.39M
Revenue Q1 2026 · Mar 31, 2025 $373.23M